Avania, a global MedTech clinical research organization (CRO), has appointed Jason Monteleone as its new president and CEO, effective September 2, 2024. Monteleone, a seasoned leader with over 25 years of experience in the CRO, medical device, and life sciences sectors, will lead Avania’s continued growth and innovation in key therapeutic areas like cardiovascular, neurology, orthopedics, and aesthetics.